CJC-1295 with DAC
Modified GRF (1-29) with Drug Affinity Complex
Long-acting GHRH analog with Drug Affinity Complex (DAC) technology enabling albumin binding for extended half-life (~6–8 days). Produces sustained GH and IGF-1 elevation versus pulsatile release from non-DAC variants. Studied for body composition, metabolic regulation, and anabolic signaling.
Sign in to view pricing and pre-order
Sign In / Register